CA2915027A1 - Compositions et procedes d'administration de vaccins contre le virus de la dengue - Google Patents
Compositions et procedes d'administration de vaccins contre le virus de la dengue Download PDFInfo
- Publication number
- CA2915027A1 CA2915027A1 CA2915027A CA2915027A CA2915027A1 CA 2915027 A1 CA2915027 A1 CA 2915027A1 CA 2915027 A CA2915027 A CA 2915027A CA 2915027 A CA2915027 A CA 2915027A CA 2915027 A1 CA2915027 A1 CA 2915027A1
- Authority
- CA
- Canada
- Prior art keywords
- dengue virus
- administration
- compositions
- methods
- vaccines against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24141—Use of virus, viral particle or viral elements as a vector
- C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/492,884 | 2012-06-10 | ||
US13/492,884 US8968996B2 (en) | 2009-06-01 | 2012-06-10 | Compositions and methods for rapid immunization against dengue virus |
PCT/US2013/045041 WO2013188315A1 (fr) | 2012-06-10 | 2013-06-10 | Compositions et procédés d'administration de vaccins contre le virus de la dengue |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2915027A1 true CA2915027A1 (fr) | 2013-12-19 |
Family
ID=48652375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2915027A Abandoned CA2915027A1 (fr) | 2012-06-10 | 2013-06-10 | Compositions et procedes d'administration de vaccins contre le virus de la dengue |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2858668A1 (fr) |
JP (2) | JP2015520196A (fr) |
CA (1) | CA2915027A1 (fr) |
NZ (1) | NZ630831A (fr) |
TW (1) | TW201402143A (fr) |
WO (1) | WO2013188315A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014093182A1 (fr) | 2012-12-14 | 2014-06-19 | Inviragen, Inc. | Compositions, procédés d'administration et utilisations de formulations trivalentes contre le virus de la dengue |
CN113637694A (zh) | 2013-03-15 | 2021-11-12 | 武田疫苗股份有限公司 | 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法 |
CA2991212A1 (fr) * | 2015-07-02 | 2017-01-05 | PrimeVax Immuno-Oncology, Inc. | Compositions et procedes pour polytherapie utilisant le virus de la dengue et des cellules dendritiques |
CA2999881A1 (fr) | 2015-09-26 | 2017-03-30 | PrimeVax Immuno-Oncology, Inc. | Compositions et procedes pour produire des cellules dendritiques |
EP3442571A1 (fr) * | 2016-04-13 | 2019-02-20 | Takeda Vaccines, Inc. | Compositions et procédés de vaccination contre le virus de la dengue chez des enfants et de jeunes adultes |
TWI625393B (zh) * | 2016-11-15 | 2018-06-01 | 國立清華大學 | 對抗複數種登革熱病毒血清型之疫苗套組及其製備方法與用途 |
JP2020500847A (ja) | 2016-11-16 | 2020-01-16 | プライムヴァックス イミュノ−オンコロジー,インク. | 癌の処置のための併用免疫療法 |
CA3049225A1 (fr) | 2017-01-04 | 2018-07-12 | PrimeVax Immuno-Oncology, Inc. | Compositions et methodes de therapie avec le virus de la dengue |
US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
ES2908304T3 (es) | 2018-09-05 | 2022-04-28 | Takeda Vaccines Inc | Dosis unitaria de vacuna contra el dengue y administración de la misma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8110196B2 (en) * | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
WO2010141386A1 (fr) * | 2009-06-01 | 2010-12-09 | Inviragen, Inc. | Compositions et procédés destinés à l'administration de vaccins contre le virus de la dengue |
US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
-
2013
- 2013-06-10 CA CA2915027A patent/CA2915027A1/fr not_active Abandoned
- 2013-06-10 NZ NZ630831A patent/NZ630831A/en not_active IP Right Cessation
- 2013-06-10 WO PCT/US2013/045041 patent/WO2013188315A1/fr active Application Filing
- 2013-06-10 JP JP2015516276A patent/JP2015520196A/ja active Pending
- 2013-06-10 EP EP13729909.5A patent/EP2858668A1/fr not_active Withdrawn
- 2013-06-10 TW TW102120553A patent/TW201402143A/zh unknown
-
2018
- 2018-02-23 JP JP2018030539A patent/JP2018090618A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2858668A1 (fr) | 2015-04-15 |
JP2015520196A (ja) | 2015-07-16 |
JP2018090618A (ja) | 2018-06-14 |
TW201402143A (zh) | 2014-01-16 |
NZ630831A (en) | 2019-02-22 |
WO2013188315A1 (fr) | 2013-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2915027A1 (fr) | Compositions et procedes d'administration de vaccins contre le virus de la dengue | |
EP4357355A3 (fr) | Purification de virus | |
HK1259355A1 (zh) | 作為btk激酶抑制劑的2,3-二氫異吲哚-1-酮衍生物、以及含有所述衍生物的藥物組合物 | |
EP2471926A3 (fr) | Oligodésoxynucléotides immunostimulateurs | |
WO2011103453A3 (fr) | Vaccins destinés à être utilisés pour la prophylaxie et le traitement d'une maladie liée au virus de la grippe | |
WO2014205389A8 (fr) | Modulateurs de transport nucléaire et leurs utilisations | |
CL2014003171A1 (es) | Composicion liofilizada que comprende al menos una benzodiazepina de formula (i), al menos un excipiente higroscopico seleccionado de disacaridos y dextrano; metodo de preparacion de la composicion farmaceutica. | |
JP2012143233A5 (fr) | ||
WO2012024621A3 (fr) | Vaccins à nanosupport synthétique comprenant des peptides obtenus ou dérivés de l'hémagglutinine du virus de la grippe a humaine | |
MX346596B (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
MX2013013801A (es) | Oligodesoxinucleotidos inmunoestimuladores. | |
WO2013170068A3 (fr) | Modulateurs du transport nucléaire et leurs utilisations | |
MX2016006053A (es) | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. | |
IL236057B (en) | History of 4,2,1-triazine-6-carboxamide and pharmaceutical preparations containing them | |
BR112015008417A8 (pt) | composição imunogênica, vacina, e, uso de uma composição imunogênica | |
MX2021013109A (es) | Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue. | |
UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
EP2931310A4 (fr) | Compositions, procédés d'administration et utilisations de formulations trivalentes contre le virus de la dengue | |
WO2015173701A3 (fr) | Compositions pharmaceutiques pour traiter des maladies infecteuses | |
AR090073A1 (es) | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos | |
MX2013003245A (es) | Vacuna contra virus de diarrea viral de bovinos. | |
IN2015DN02335A (fr) | ||
WO2014140166A3 (fr) | Vaccin | |
EP2551266A4 (fr) | Composés non nucléosidiques de 2',2-dithiazole, leurs procédés de préparation, compositions pharmaceutiques et utilisations en tant qu'inhibiteurs de virus de l'hépatite | |
WO2016141320A3 (fr) | Virus non neuro-invasifs et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20151210 |
|
FZDE | Dead |
Effective date: 20200831 |